These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35380381)

  • 21. Successful parathyroidectomy with intra-operative parathyroid hormone monitoring in a neonate with severe primary hyperparathyroidism caused by homozygous mutation in CASR gene.
    Sorapipatcharoen K; Mahachoklertwattana P; Tim-Aroon T; Wattanasirichaigoon D; Karanes S; Molagool S; Poomthavorn P
    J Paediatr Child Health; 2020 Jul; 56(7):1144-1146. PubMed ID: 31883284
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypocalciuric hypercalcemia presenting as neonatal rib fractures: a newly described mutation of the calcium-sensing receptor gene.
    Nyweide K; Feldman KW; Gunther DF; Done S; Lewis C; Van Eenwyk C
    Pediatr Emerg Care; 2006 Nov; 22(11):722-4. PubMed ID: 17110864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Pidasheva S; D'Souza-Li L; Canaff L; Cole DE; Hendy GN
    Hum Mutat; 2004 Aug; 24(2):107-11. PubMed ID: 15241791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT).
    Rodrigues LS; Cáu AC; Bussmann LZ; Bastida G; Brunetto OH; Corrêa PH; Martin RM
    Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):67-71. PubMed ID: 21468522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications.
    Eldeiry LS; Ruan DT; Brown EM; Gaglia JL; Garber JR
    Endocr Pract; 2012; 18(3):412-7. PubMed ID: 22232026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia.
    Hannan FM; Nesbit MA; Christie PT; Lissens W; Van der Schueren B; Bex M; Bouillon R; Thakker RV
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):715-22. PubMed ID: 20846291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal severe hyperparathyroidism: A case report.
    Shaukat M; Ahmad HM; Shafiq MU
    J Pak Med Assoc; 2022 Dec; 72(12):2538-2541. PubMed ID: 37246686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Progress in diagnosis and therapy: Hypercalcemia due to primary hyperparathyroidism].
    Sugimoto T
    Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):662-8. PubMed ID: 17506301
    [No Abstract]   [Full Text] [Related]  

  • 29. Personalised medicines for familial hypercalcemia and hyperparathyroidism.
    Josephs TM; Zhang F; Dinh LV; Keller AN; Conigrave AD; Capuano B; Gregory KJ; Leach K
    J Mol Endocrinol; 2022 May; 69(1):243-257. PubMed ID: 35318962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcet.
    Reh CM; Hendy GN; Cole DE; Jeandron DD
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E707-12. PubMed ID: 21289269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary hyperparathyroidism in a patient with familial hypocalciuric hypercalcaemia due to a novel mutation in the calcium-sensing receptor gene.
    Egan AM; Ryan J; Aziz MA; O'Dwyer TP; Byrne MM
    J Bone Miner Metab; 2013 Jul; 31(4):477-80. PubMed ID: 23081733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cinacalcet therapy in an infant with an R185Q calcium-sensing receptor mutation causing hyperparathyroidism: a case report and review of the literature.
    Forman TE; Niemi AK; Prahalad P; Shi RZ; Nally LM
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):305-310. PubMed ID: 30730839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor].
    Watanabe S; Fukumoto S
    Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations.
    Egbuna OI; Brown EM
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):129-48. PubMed ID: 18328986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium signaling regulates trafficking of familial hypocalciuric hypercalcemia (FHH) mutants of the calcium sensing receptor.
    Grant MP; Stepanchick A; Breitwieser GE
    Mol Endocrinol; 2012 Dec; 26(12):2081-91. PubMed ID: 23077345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial Hypocalciuric Hypercalcemia and Neonatal Severe Hyperparathyroidism.
    Vannucci L; Brandi ML
    Front Horm Res; 2019; 51():52-62. PubMed ID: 30641521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium of 28mg/dL in patient of 4 days of life. Urgent treatment and follow-up.
    Segura González M; Carrasco Hidalgo-Barquero MC; Hidalgo-Barquero Del Rosal E
    Nefrologia (Engl Ed); 2019; 39(5):552-554. PubMed ID: 30857752
    [No Abstract]   [Full Text] [Related]  

  • 38. A Case of a Heterozygous Inactivating CASR Variant with Adult-Onset Symptomatic Hypercalcemia Requiring Extensive Surgery.
    Veldeman L; Robbrecht S; Breckpot J; Weynand B; Decallonne B
    Calcif Tissue Int; 2020 Jul; 107(1):104-108. PubMed ID: 32306059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
    Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A homozygous CaSR mutation causing a FHH phenotype completely masked by vitamin D deficiency presenting as rickets.
    Szczawinska D; Schnabel D; Letz S; Schöfl C
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E1146-53. PubMed ID: 24517148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.